1. Home
  2. APRE vs AIRI Comparison

APRE vs AIRI Comparison

Compare APRE & AIRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • AIRI
  • Stock Information
  • Founded
  • APRE 2006
  • AIRI 1979
  • Country
  • APRE United States
  • AIRI United States
  • Employees
  • APRE N/A
  • AIRI N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • AIRI Military/Government/Technical
  • Sector
  • APRE Health Care
  • AIRI Industrials
  • Exchange
  • APRE Nasdaq
  • AIRI Nasdaq
  • Market Cap
  • APRE 13.5M
  • AIRI 13.4M
  • IPO Year
  • APRE 2019
  • AIRI N/A
  • Fundamental
  • Price
  • APRE $1.50
  • AIRI $3.24
  • Analyst Decision
  • APRE Strong Buy
  • AIRI
  • Analyst Count
  • APRE 2
  • AIRI 0
  • Target Price
  • APRE $15.50
  • AIRI N/A
  • AVG Volume (30 Days)
  • APRE 29.2K
  • AIRI 12.9K
  • Earning Date
  • APRE 05-13-2025
  • AIRI 04-15-2025
  • Dividend Yield
  • APRE N/A
  • AIRI N/A
  • EPS Growth
  • APRE N/A
  • AIRI N/A
  • EPS
  • APRE N/A
  • AIRI N/A
  • Revenue
  • APRE $1,502,581.00
  • AIRI $55,108,000.00
  • Revenue This Year
  • APRE N/A
  • AIRI $1.80
  • Revenue Next Year
  • APRE N/A
  • AIRI N/A
  • P/E Ratio
  • APRE N/A
  • AIRI N/A
  • Revenue Growth
  • APRE 157.63
  • AIRI 6.97
  • 52 Week Low
  • APRE $1.41
  • AIRI $3.00
  • 52 Week High
  • APRE $5.90
  • AIRI $9.44
  • Technical
  • Relative Strength Index (RSI)
  • APRE 27.07
  • AIRI 41.93
  • Support Level
  • APRE $1.41
  • AIRI $3.02
  • Resistance Level
  • APRE $1.59
  • AIRI $3.36
  • Average True Range (ATR)
  • APRE 0.11
  • AIRI 0.18
  • MACD
  • APRE 0.02
  • AIRI 0.01
  • Stochastic Oscillator
  • APRE 18.60
  • AIRI 47.06

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About AIRI Air Industries Group

Air Industries Group is an aerospace and defense company. Its manufactures and designs structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants, jet engines, and other components. The company also provides sheet metal fabrication of aerostructures, tube bending, and welding services.

Share on Social Networks: